Annual ReportFiscal Year Ended Mar. 31, 2017
Goals of Olympus
Who We Are
Corporate Value Improvement and Management Strategy
- Topics from Fiscal 2017 and More Recently
- Financial / Non-Financial Highlights
- Message from the President
- Special Feature 1: Growth Strategies for Businesses and Functions-CxO Messages (CFO, CCO, CMAO, CQO, CIO, CAO, CTO, CMO, CSMO)
- Special Feature 2: Expansion of Businesses in Growth-Driving Emerging Countries
- At a Glance / Review of Business Segments (Medical Business / Scientific Solutions Business / Imaging Business)
Management Resources Supporting Our Competitive Edge
- R&D Activities / Intellectual Property Activities / Human Resources
- Discussion between a Long-Term Investor and an Outside Director (Chairman of the Board of Directors)
- Corporate Governance / Compliance / Risk Management / CSR Management / Environmental Management
- Directors and Audit & Supervisory Board Members
Fact Data
- 10-Year Financial / Non-Financial Data
- Analysis of Business Results, Financial Position, and Cash Flows
- Risk Information
- Consolidated Financial Statements and Notes / Independent Auditor's Report
- Olympus Group Companies
- Corporate Information
- FY Ended Mar. 31, 2025
- FY Ended Mar. 31, 2024
- FY Ended Mar. 31, 2023
- FY Ended Mar. 31, 2022
- FY Ended Mar. 31, 2021
- FY Ended Mar. 31, 2020
- FY Ended Mar. 31, 2019
- FY Ended Mar. 31, 2018
- FY Ended Mar. 31, 2017
- FY Ended Mar. 31, 2016
- FY Ended Mar. 31, 2015
- FY Ended Mar. 31, 2014
- FY Ended Mar. 31, 2013
- FY Ended Mar. 31, 2012